The truth will out.
by Dr. Joseph Mercola STORY-AT-A-GLANCE An advisory panel to the U.S. Food and Drug Administration voted to grant emergency authorization to Merck’s oral COVID-19 pill molnupiravir (Lagevrio) — by a narrow 13-to-10 margin Among those who received the drug, the rate of all-cause hospitalization or death was 6.8%, compared to 9.7% in the placebo group […]
by Valerie Donaldson, MD New Oral Pharmaceutical Agents For Mild to Moderate COVID-19 As it is becoming more clear vaccines do not stop the spread of COVID-19, but may be instrumental in shortening the length of illness, symptoms, and decrease hospitalizations; two large pharmaceutical companies, Merck and Pfizer, have come forward with press releases regarding […]
by David Henderson and Charles Hooper via The American Institute for Economic Research On July 28, the Wall Street Journal ran our article “Why Is the FDA Attacking a Safe, Effective Drug?” In it, we outlined the potential value of the antiparasitic drug ivermectin for Covid-19, and we questioned the FDA’s vigorous attack on ivermectin. Many […]
written by Paul Craig Roberts The criminal organization, Merck, announced today that they filed an “emergency use authorization” request with the company’s agent, the FDA, for an oral antiviral medicine for treating Covid-19. Former FDA commissioner and shill for Big Pharma, Scott Gottlieb, lobbied for the emergency use authorization on CNBC, declaring the untested pill […]